Phenformin
From Wikipedia, the free encyclopedia
Phenformin
|
|
Systematic (IUPAC) name | |
2-(N-phenethylcarbamimidoyl)guanidine | |
Identifiers | |
CAS number | |
ATC code | A10 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C10H15N5 |
Mol. mass | 205.26 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Phenformin is an anti-diabetic drug from the biguanide class. It is no longer widely available because it is known to induce lactic acidosis.[1]
Like metformin, phenformin leads to weight loss, something often desirable in type 2 diabetics, and it is for this reason that there is still some interest in it.[2]
[edit] References
- ^ Enia G, Garozzo M, Zoccali C (1997). "Lactic acidosis induced by phenformin is still a public health problem in Italy.". BMJ 315 (7120): 1466-7. PMID 9418116. Free Full Text.
- ^ Rosand J, Friedberg J, Yang J (1997). "Fatal phenformin-associated lactic acidosis.". Ann Intern Med 127 (2): 170. PMID 9230023. . Free Full Text